Lanean...
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
BACKGROUND: Laquinimod is an immunomodulatory drug under clinical investigation for the treatment of the progressive form of multiple sclerosis (MS) with both anti-inflammatory and neuroprotective effects. Excitotoxicity, a prominent pathophysiological feature of MS and of its animal model, experime...
Gorde:
| Argitaratua izan da: | J Neuroinflammation |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756343/ https://ncbi.nlm.nih.gov/pubmed/29304807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-1048-6 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|